Inhaled treprostinil in pulmonary hypertension associated with COPD: PERFECT study results.
Steven D NathanRahul ArgulaMaria G TrivieriSameh AzizElizabeth GayBoris MedarovJoseph ParambilAmresh RainaMichael G RisbanoThenappan ThenappanJose Soto SotoHeidi BellVictoria LacassePrakash SistaMichael Di MarinoAimee SmartBrittanie HawkesElizabeth NelsonTodd BullVictor TapsonAaron B WaxmanPublished in: The European respiratory journal (2024)
The risk-benefit observations associated with iTRE in patients with PH-COPD did not support continuation of the PERFECT study. The results of this study do not support iTRE as a viable treatment option in patients with PH-COPD.